Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07125261) titled 'BHV-7000 Responsive Neurostimulation System (RNS) Study' on Aug. 8.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Yale University
Condition:
Epilepsy
Seizures
Intervention:
Drug: BHV-700
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: September 2025
Target Sample Size: 5
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07125261
Published by HT Digital Content Services with permission from Health ...